My Therapy Journal Shark Tank Update: The App That Predicted the $10B Mental Health Boom
If you are a fan of Shark Tank, you might remember the very first season. Long before the show became a global hit, early entrepreneurs stepped onto the stage with ideas that were often years ahead of their time. One of those early ideas was My Therapy Journal.
Pitched as an online tool for mental health self-care, My Therapy Journal was designed to combine the proven benefits of therapy with the privacy of the internet.
Today, in 2026, using an app on your phone to track your mood or chat with an AI therapist is completely normal. But back in 2009, this was a radical idea.
In this complete 2026 update, we look back at the My Therapy Journal pitch, what happened to the founders after the cameras stopped rolling, and how this young startup successfully predicted the massive $10 billion digital mental health market we see today.
What Is My Therapy Journal?
My Therapy Journal was an online platform that provided a private, secure, and personalized journaling experience. Built long before the modern smartphone app boom, it was created as a therapeutic tool to help users process their emotions, reflect on their feelings, and improve their overall mental health.
The platform was highly interactive and user-friendly. It offered tools to help people with personal reflection and emotional processing. It was based on proven psychological methods like Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT).
Some of the core features of My Therapy Journal included:
- Mood Tracking: Users could log how they felt each day, creating a visual map of their emotional highs and lows over time.
- Personalized Prompts: The system gave users specific writing prompts to guide their journaling and self-discovery.
- Goal Setting: Users could set actual targets for their mental health journey and track their progress toward them.
- Progress Reports: The platform created graphs and visual reports to show users how much they had grown.
The main appeal of My Therapy Journal was its convenience and low cost. It allowed people to do therapy-like exercises at their own pace, right from their living room.
It was meant to be a helpful tool for people who did not have the time, money, or resources for traditional, in-person therapy.
Who Are the Founders of My Therapy Journal?
The founders of My Therapy Journal are brothers Rodolfo and Alexis Saccoman. Their story is a classic example of the American Dream.
Originally from Brazil, the brothers moved to the United States when they were children. Their father was a dedicated, hard worker who saw an opportunity for his sons to learn English and build a better life.
While working in a factory, their father managed to earn a high school diploma, a college degree, and two master’s degrees. His incredible work ethic deeply inspired both Rodolfo and Alexis.
The brothers grew up to be highly successful in their own fields, bringing two very different skill sets to their business:
- Alexis Saccoman attended Brown University and became a practicing therapist based in San Francisco. He had the clinical knowledge needed to make sure the platform’s therapy exercises actually worked.
- Rodolfo Saccoman graduated from Cornell University and became the director of online marketing for a major resort chain in Palm Beach, Florida. He had the business and marketing skills needed to sell the product.
The duo combined their skills to create My Therapy Journal. Before they even appeared on Shark Tank, the Saccoman brothers had invested a massive portion of their own savings into the business. They spent $125,000 to get the company off the ground, with about 95% of that money going directly into developing the custom software.
The Shark Tank Pitch: Season 1, Episode 5
The Saccoman brothers appeared on Season 1, Episode 5 of Shark Tank, which aired in September 2009. They walked into the tank seeking an $80,000 investment in exchange for 20% equity in their company. This meant they valued My Therapy Journal at $400,000.
They started their pitch with a smart, interactive exercise. They asked the Sharks to close their eyes and think of something that made them happy. This immediately grabbed the investors’ attention and showed them the power of mental focus.
The brothers then explained their subscription model. Users could pay between $7.95 and $14.95 per month to use the platform, depending on how long they signed up for.
However, when the Sharks started asking about the numbers, the pitch hit a major speed bump.
| My Therapy Journal Pitch Facts | The Numbers |
| Initial Investment Asked | $80,000 |
| Equity Offered | 20% |
| Company Valuation | $400,000 |
| Total Free Trial Users | 1,120 |
| Total Paying Customers | 121 |
| Previous Year Revenue | $4,000 |
Data sourced from the original 2009 Shark Tank broadcast.
Despite the great idea, the business was struggling to make money. They only made $4,000 in the entire year before the show.
Out of the 1,120 people who signed up for a free trial, only 121 people actually paid for a subscription. Because they spent all their money building the software, they had no money left for marketing to find new customers.
Hearing these low sales numbers, Sharks Barbara Corcoran and Kevin Harrington dropped out early.
But then, the brothers dropped a major hint: they were currently in talks with Aetna, a massive health insurance company. If Aetna agreed to offer My Therapy Journal to its millions of insured customers, the startup would become an overnight goldmine.
Hearing this, Kevin O’Leary and Robert Herjavec teamed up. They offered the brothers the $80,000 they asked for, but they wanted a controlling 51% stake in the company.
Their offer was firmly tied to the brothers successfully closing the deal with Aetna. Daymond John also jumped in, offering $120,000 for 50%.
The brothers did not want to lose control of their company. They tried to negotiate Robert and Kevin down to 49%. But the Sharks held firm. Eventually, Alexis and Rodolfo accepted the deal: $80,000 for 51% equity.
What Happened to My Therapy Journal After Shark Tank?
Unfortunately, the success you see on TV does not always translate to the real world. My Therapy Journal did not survive after Shark Tank.
After the episode aired, the brothers received hundreds of new sign-ups and great reviews from users who loved the platform. But the exciting deal they made with Kevin O’Leary and Robert Herjavec never actually closed.
According to the brothers, after the show ended, they got exactly one phone call from the two Sharks. After that, they heard nothing. There was no follow-up, and they never received the $80,000 investment.
Without the cash injection from the Sharks, and with no money of their own left for marketing, the company was in trouble.
Furthermore, the massive partnership with the Aetna insurance company never worked out. Without the insurance deal, it was simply too hard to get enough paying customers to keep the website running.
In December 2009, just a few months after their episode aired, the brothers officially shut down My Therapy Journal.
Where Are the Founders Now? (2026 Update)
While the business did not succeed, the founders went on to do incredible things. Here is a complete 2026 update on where the Saccoman brothers are today.
The Lasting Legacy of Alexis Saccoman
After the company closed, Alexis returned to his passion: helping people directly. He went back to his private psychology practice.
From 2013 to 2017, Alexis served as the Program Director for an organization called AFY iTHRIVE. This was an early intervention program designed to help teenagers who were struggling with substance use and minor criminal offenses. He also returned to his alma mater, Brown University, every year to give highly popular lectures to students.
Tragically, Alexis Saccoman passed away on May 30, 2018. His death was a massive loss to his family, his patients, and his community. However, his work left a permanent mark. In June 2018, the AFY community training program was renamed the Dr. Alexis Saccoman Training Institute to honor his lifelong commitment to helping young people.
Rodolfo Saccoman’s Massive Success in VR and AI
Rodolfo Saccoman took the lessons he learned from My Therapy Journal and became a highly successful tech entrepreneur. He moved into the world of Artificial Intelligence (AI) and Virtual Reality (VR).
In 2012, Rodolfo founded AdMobilize, an AI tech company. The company built AI sensors that could track how people interacted with physical billboards and retail stores in real-time. Rodolfo likes to call it “Google Analytics for the physical world.” The company was a massive hit, raising $13 million in funding before eventually being acquired.
Today, in 2026, Rodolfo is the CEO and Co-Founder of VRAL Games, a major video game company based in Miami. The company focuses on mixed reality and fully immersive VR games for headsets like the Meta Quest.
| Rodolfo Saccoman’s Tech Career | Company Focus | Status in 2026 |
| My Therapy Journal | Online Mental Health | Closed (2009) |
| AdMobilize | AI Sensors for Advertising | Raised $13M, Acquired |
| VRAL Games | Virtual Reality Gaming | Active, CEO |
Under Rodolfo’s leadership, VRAL Games has released several huge titles. In 2024, they launched VRIDER, the first official VR racing game for the Superbike World Championship.
To stop players from getting dizzy while racing at 200 mph in virtual reality, Rodolfo and his team invented special software called MotionWellness™ Technology.
By 2025, his company had grown so much that they bought a 30% stake in PolarityOne, a studio making a massive sci-fi VR shooter game called EXOSHOCK.
Even Facebook’s parent company, Meta, has invested in his games. Rodolfo is now a leading voice in the multi-billion dollar tech world.
Is My Therapy Journal Still In Business Today?
No, My Therapy Journal is definitely no longer in business. The platform officially shut down in December 2009.
If you try to visit their old website today, the page does not load. The Facebook page for the business has also not been updated since 2009.
What Is the Net Worth of My Therapy Journal?
Because the company has been out of business for nearly two decades, the net worth of My Therapy Journal is $0.
When they pitched on Shark Tank in 2009, they asked for a $400,000 valuation. The final deal they accepted valued the company at roughly $160,000. However, since the deal never closed and the site shut down, all of that value vanished.
That being said, Rodolfo Saccoman has built a massive personal net worth since then. His later company, AdMobilize, raised $13 million, and his current venture, VRAL Games, has investments from giant tech companies like Meta.
How My Therapy Journal Predicted the 2026 Mental Health App Boom
When we look back at My Therapy Journal from the perspective of 2026, it is clear that the Saccoman brothers did not have a bad idea. They were just 15 years too early.
In 2009, people were not used to paying monthly subscriptions for websites, and dealing with mental health online felt strange. Today, that has completely changed.
A $10 Billion Market in 2026
Since the Covid-19 pandemic, the world has fully embraced digital therapy. By 2026, the global mental health apps market has exploded to a massive $10.06 billion in value. Experts expect this market to keep growing by over 17% every single year, reaching over $41 billion by 2035.
Giant companies like BetterHelp and Talkspace now dominate the exact space My Therapy Journal tried to invent. Talkspace even uses AI to summarize notes for its therapists, and BetterHelp has over 35,000 licensed professionals online.
The AI Journaling Revolution
Today, the idea of an online journal has been supercharged by Artificial Intelligence. Modern users do not just type their feelings into a blank screen. They talk to AI bots that actually reply, offering real-time therapy support.
Here are some of the biggest AI journaling apps in 2026 that follow the exact path My Therapy Journal started:
- Rosebud: This app uses prompts designed by real therapists. The AI spots patterns in your mood over time and gives you weekly insights.
- Mindsera: Known as “the journal that reflects back,” this app gives you a running commentary on your thoughts, helping you understand your fears and frustrations instantly.
- Wysa: This app acts as a “coach in your pocket.” It gives you daily journaling prompts and offers over 150 therapeutic exercises like breathing and sleep guides.
- Reflection: This app offers a clean design with bank-level encryption to keep your thoughts totally private. It even uses AI pattern recognition across all your past journal entries.
Recent studies in 2026 show that these AI therapy bots actually work. In a clinical trial for an AI called Therabot, users saw their depression symptoms drop by 51% after just four weeks.
Strict New 2026 Privacy Laws
One big difference between 2009 and 2026 is how strictly the government controls these apps. Back when My Therapy Journal launched, the rules around digital health data were very loose. Today, protecting patient data is a top priority.
In February 2026, the government launched strict new updates to HIPAA (the main health privacy law in the US). Any app that handles mental health data must now have military-grade encryption. They must use a “Zero-Trust” system, which means every single user login requires multi-factor authentication (like getting a text code to your phone).
Furthermore, because some rogue AI chatbots have given users dangerous advice, many US states passed strict new laws in 2026.
Health apps must now clearly tell users when they are talking to a robot instead of a human. The apps are also legally required to instantly connect a user to a human crisis hotline if the AI detects that the person wants to harm themselves.
Final Thoughts: A Visionary Idea Ahead of Its Time
The story of My Therapy Journal is a perfect example of how timing is everything in business. Alexis and Rodolfo Saccoman were brilliant innovators. They clearly saw that the future of mental healthcare was going to happen on digital screens. They understood that journaling and CBT could be brought to the masses using technology.
They failed simply because the world was not ready yet. They lacked the marketing money to educate consumers, and they didn’t have the smartphones, the AI, or the modern insurance laws to support their dream.
Today, as we look at the booming $10 billion industry filled with AI chatbots and telehealth giants, it is clear that the Saccoman brothers were right all along. Though the company is gone, Alexis’s clinical legacy lives on, and Rodolfo’s massive success in the tech world proves that their entrepreneurial spirit never faded.
